CD1d Activation and Blockade: A New Antitumor Strategy

Journal of Immunology - United States
doi 10.4049/jimmunol.0802964
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery

English

JNK2 Modulates the CD1d-dependent and -Independent Activation of iNKT Cells

European Journal of Immunology
AllergyImmunology
2018English

Robust Antitumor Responses Result From Local Chemotherapy and CTLA-4 Blockade

Cancer immunology research
Cancer ResearchImmunology
2018English

A New Antitumor Antibiotic, Dioxolamycin.

Journal of Antibiotics
Drug DiscoveryPharmacology
1984English

A New Antitumor Antibiotic: Demethylstreptonigrin.

Journal of Antibiotics
Drug DiscoveryPharmacology
1986English

Tetrocarcins, New Antitumor Antibiotics. 3. Antitumor Activity of Tetrocarcin A.

Journal of Antibiotics
Drug DiscoveryPharmacology
1982English

Emerging a New Strategy for the Antitumor Immunotherapy: Pharmacological Modulation of the Ca2+/Camp Signaling Interaction

Archives of Microbiology & Immunology
2017English

A New HOPE for Aldosterone Blockade?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Activation of Potassium Channel as a New Strategy to Boost Antitumour Immune Response

Biophysical Journal
Biophysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy